SCHEMBL19334492

SCHEMBL19334492

Cc1cc(Br)c(NCC(=O)N/N=C/c2cc([N+](=O)O)ccc2O)c(Br)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIG1 P18858 2/20 0.62
LIG3 P49916 1/20 0.62
ALDH1A1 P00352 3/20 0.53
MAPT P10636 11/20 0.49
KDM4E B2RXH2 9/20 0.49
HTT P42858 8/20 0.49
KMT2A Q03164 8/20 0.49
LMNA P02545 6/20 0.49
MEN1 O00255 6/20 0.49
TDP1 Q9NUW8 3/20 0.48
THRB P10828 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
POLB P06746 1/20 0.47
ERCC1 P07992 1/20 0.46
ERCC4 Q92889 1/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
TP53 P04637 1/20 0.46
HPGD P15428 1/20 0.46
HSD17B3 P37058 1/20 0.45
HSD17B2 P37059 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13401821 0.91 LIG1 (0.75) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL19334306 0.86 LIG1 (0.83) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL19334394 0.82 ALDH1A1 (0.59) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL19298155 0.77 LIG1 (1.00) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL13401789 0.77 LIG1 (1.00) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL13401792 0.76 KDM4E (0.63) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL19334390 0.73 MEN1 (0.58) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL13745514 0.72 MAPT (0.67) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL19334542 0.71 L3MBTL1 (0.83) ALDH1A1MAPTKDM4EHTTKMT2A
SCHEMBL19334395 0.68 KDM4E (0.52) LIG1LIG3ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9757375-B2 Compounds that inhibit human DNA ligases and methods of treating cancer UNIVERSITY OF MARYLAND, BALTIMORE (US) 2017-09-12 US disclosed